Premature Infants in Need of Transfusion (PINT)
A Randomized Controlled Trial of Two Hemoglobin Thresholds for Transfusion in Newborns <1000g Birth Weight
3 other identifiers
interventional
424
3 countries
10
Brief Summary
Hypothesis: That a high hemoglobin threshold for transfusion in extremely low birth weight (ELBW) infants is associated with a lower rate of survival without severe morbidity (defined as one or more of retinopathy of prematurity, bronchopulmonary dysplasia, or periventricular leukomalacia/ventriculomegaly). Primary Objective: To determine whether either a liberal or more restrictive threshold of hemoglobin level for red cell transfusion in ELBW infants is safer, by randomizing to either a high transfusion hemoglobin threshold or a low transfusion hemoglobin threshold. Follow-up at a corrected age of 18 months represents a conventional age at which to first assess neurodevelopmental outcomes, and to predict long-term outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Feb 2001
Longer than P75 for phase_3
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 16, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2005
CompletedSeptember 24, 2015
September 1, 2015
2 years
September 13, 2005
September 22, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Combined mortality or survival to tertiary hospital discharge without severe morbidity (BPD, severe ROP or brain injury)
neonatal phase
Combined mortality or survival with neurodevelopmental disability (non-ambulatory cerebral palsy, blindness, deafness, cognitive delay)
follow-up phase 18 months corrected age
Secondary Outcomes (20)
growth in weight and head circumference
neonatal phase
time to extubation
neonatal phase
time on oxygen
neonatal phase
length of hospital stay until discharge home
neonatal phase
confirmed necrotizing enterocolitis
neonatal phase
- +15 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- birth weight \<1000g
- postnatal age \<48 hours
- no transfusion beyond first 6 hours of life
- estimated gestational age of 30 completed weeks or less
You may not qualify if:
- infant considered non-viable by attending physician
- infant has cyanotic congenital heart disease
- infant's parents known to be opposed to blood transfusion
- either parent has hemoglobinopathies or congenital anemias
- infant has hemolytic disease
- infant has severe acute hemorrhage, severe shock, severe sepsis with coagulopathy or requires peri-operative transfusion
- prior treatment with or intention to treat with erythropoietin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McMaster Universitylead
- Canadian Institutes of Health Research (CIHR)collaborator
Study Sites (10)
Albany Medical Center
Albany, New York, 12208, United States
Brooklyn Hospital Center
Brooklyn, New York, 11201, United States
Royal Women's Hospital
Melbourne, Victoria, 3053, Australia
Mercy Hospital for Women
Melbourne, Victoria, 3084, Australia
Royal Alexandra Hospital
Edmonton, Alberta, T5H 3T9, Canada
IWK Health Centre
Halifax, Nova Scotia, B3P 1R8, Canada
McMaster University
Hamilton, Ontario, L8S 4J9, Canada
Kingston General Hospital
Kingston, Ontario, K7L 2V7, Canada
Sunnybrook & Women's College Health Science Centre
Toronto, Ontario, M5S 1B2, Canada
Royal Victoria Hospital
Montreal, Quebec, H3A 1A1, Canada
Related Publications (2)
Kirpalani H, Whyte RK, Andersen C, Asztalos EV, Heddle N, Blajchman MA, Peliowski A, Rios A, LaCorte M, Connelly R, Barrington K, Roberts RS. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006 Sep;149(3):301-307. doi: 10.1016/j.jpeds.2006.05.011.
PMID: 16939737RESULTWhyte RK, Kirpalani H, Asztalos EV, Andersen C, Blajchman M, Heddle N, LaCorte M, Robertson CM, Clarke MC, Vincer MJ, Doyle LW, Roberts RS; PINTOS Study Group. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics. 2009 Jan;123(1):207-13. doi: 10.1542/peds.2008-0338.
PMID: 19117884RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Haresh Kirpalani, MD, MSc
McMaster University
- PRINCIPAL INVESTIGATOR
Robin K Whyte, MD
Dalhousie University
- STUDY DIRECTOR
Robin S Roberts, MTech
McMaster University
- STUDY DIRECTOR
Elizabeth Asztalos, MD, MSc
Sunnybrook & Women's College Health Sciences Centre
- STUDY DIRECTOR
Chad Andersen, MD
Mercy Hospital for Women
- STUDY DIRECTOR
Morris Blajchman, PhD
McMaster University
- STUDY DIRECTOR
Nancy Heddle, MSc
McMaster University
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 16, 2005
Study Start
February 1, 2001
Primary Completion
February 1, 2003
Study Completion
November 1, 2005
Last Updated
September 24, 2015
Record last verified: 2015-09